Used in pharmaceutical research as an intermediate in the synthesis of biologically active compounds, particularly those targeting neurological pathways. Shows potential in the development of agents affecting dopamine and serotonin systems due to its structural similarity to known neuroactive molecules. Also employed in studies related to Parkinson’s disease and other neurodegenerative conditions, where tetrahydroisoquinoline derivatives may play a role in understanding disease mechanisms or designing protective agents.